Inflammatory Responses to Acute and Chronic Opioid Exposure in Humans

• Status: Terminated
• Trial end date: 2013-07-01
• Target enrollment: 0
• Participant gender: All

Summary

We aim to examine the extent to which inflammation is affected by acute and chronic opioid exposure.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Stanford University
• Treatments: Analgesics, Opioid; Morphine

Criteria

Inclusion Criteria:

• 18-60 years old

• Healthy volunteer

• Not allergic to remifentanil

Exclusion Criteria:

• Patients younger than 18 or older than 70

• Patients unwilling or unable to follow study instructions

• Patients who don't speak English

• Patients who are taking prescription opioid medications (e.g. vicodin, percocet) or are unwilling to refrain from taking anti-inflammatory medications such as Advil or Naproxen during 2 weeks prior to and during the 1 month study